Capital Impact Advisors, LLC Medpace Holdings, Inc. Transaction History

Capital Impact Advisors, LLC

$75.1 Million
Q1 2024

A detailed history of Capital Impact Advisors, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 3,030 shares of MEDP stock, worth $1.23 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

3,030

Previous 3,030 -0.0%

Holding current value

$1.23 Million

Previous $928,000 31.9%

% of portfolio

1.63%

Previous 1.24%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $97,378 - $133,827	-428 Reduced 12.38%	3,030 $928,000
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $261,355 - $314,625	1,117 Added 47.71%	3,458 $837,000
Q1 2023 May 23, 2023	BUY	$174.31 - $239.52 $408,059 - $560,716	2,341 New	2,341 $440,000
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $1.21 Million - $1.86 Million	-8,698 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$158.62 - $194.3 $1.43 Million - $1.75 Million	-9,000 Reduced 50.85%	8,698 $1.54 Million

Q2 2020 Aug 17, 2020	SELL	$68.08 - $95.68 $826,218 - $1.16 Million	-12,136 Reduced 40.68%	17,698 $1.65 Million
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $58,871 - $97,260	954 Added 3.3%	29,834 $2.19 Million
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $143,313 - $173,088	2,045 Added 7.62%	28,880 $2.43 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $426,991 - $587,917	-6,845 Reduced 20.32%	26,835 $2.23 Million
Q2 2019 Jul 19, 2019	BUY	$53.64 - $65.42 $44,789 - $54,625	835 Added 2.54%	33,680 $2.16 Million
Q4 2018 Mar 08, 2019	SELL	$46.97 - $63.98 $325,314 - $443,125	-6,926 Reduced 17.41%	32,845 $1.7 Million
Q1 2018 Apr 11, 2018	BUY	$32.03 - $39.05 $1.27 Million - $1.55 Million	39,771 New	39,771 $1.39 Million

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Account

Capital Impact Advisors, LLC Medpace Holdings, Inc. Transaction History